Marimed (MRMD) Capital Expenditures (2014 - 2026)

Marimed (MRMD) has 13 years of Capital Expenditures data on file, last reported at $19000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 92.86% year-over-year to $19000.0 in Q1 2026; TTM through Mar 2026 was $4.4 million, a 14.83% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, down 78.21% from the prior year.
• Capital Expenditures for Q1 2026 stood at $19000.0, down from $1.5 million in the prior quarter.
• Over the last five years, Capital Expenditures for MRMD reached as high as $5.4 million in Q4 2023 and fell as low as -$19000.0 in Q1 2023.
• Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $1.3 million in 2022.
• Across the five-year window, Capital Expenditures jumped 23517.65% in 2022 and tumbled 100.47% in 2023, its largest moves.
• Year by year, Capital Expenditures stood at $1.1 million in 2022, then soared by 389.18% to $5.4 million in 2023, then slumped by 80.34% to $1.1 million in 2024, then soared by 39.13% to $1.5 million in 2025, then tumbled by 98.71% to $19000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $19000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.